Skip to Main Content

Paper Details

Safety of Dual-Antiplatelet Therapy After Myocardial Infarction Among Patients With Chronic Kidney Disease.
J Am Heart Assoc
14
2019
ADP, Acute Coronary Syndrome, CKD, Chronic Kidney Disease, MI, Myocardial Infarction, P2Y12, Patients, acute MI, acute myocardial infarction, chronic kidney disease, patients, prasugrel, ticagrelor
Author NameAffiliation
John C Messenger4 Division of Cardiology University of Colorado School of Medicine Aurora CO.
Eric D Peterson1 Department of Medicine Duke University Medical Center Durham NC.
Eric D Peterson1 Department of Medicine Duke University Medical Center Durham NC.
Tracy Y Wang1 Department of Medicine Duke University Medical Center Durham NC.
  • 1 - 4

Datasets

Release 1.2